OR4F28P

Across TCGA pan-cancer cohorts, OR4F28P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR4F28P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher OR4F28P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR4F28P expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

KIRP, HNSC, and LAML are the cancer types where OR4F28P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.423	0.848	<.001	117	view →
HNSC	DFS	Tertile	All	0.142	0.628	.005	72	view →
LAML	DFS	Tertile	All	0.178	0.581	.008	54	view →
KIRC	DFS	Tertile	IV	0.173	0.630	.001	36	view →
THYM	DFS	Tertile	All	0.075	0.885	<.001	36	view →
MESO	DFS	Tertile	II,III,IV	0.039	0.407	<.001	36	view →
GBM	DFS	Tertile	All	0.072	0.259	.002	27	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	18	view →
BRCA	DFS	Tertile	All	1.000	0.515	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR4F28P–KIRP (OS)

Open the KIRP breakdown →